Table 1 Baseline clinical and pathological features of patients with bladder cancer
From: MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer
Gender | Age | Tumor grade |
|---|---|---|
M | 84 | Low-grade Ta |
M | 63 | Low-grade Ta |
M | 77 | Low-grade Ta |
M | 66 | Low-grade Ta |
M | 66 | Tis |
F | 87 | High-grade Ta |
M | 69 | High-grade Ta |
M | 74 | High-grade Ta |
M | 64 | High-grade Ta |
M | 64 | High-grade T1 |
M | 72 | High-grade T1 Tis |
M | 66 | High-grade T1, Tis |
M | 79 | High-grade T1, Tis |
M | 57 | High-grade T2, Tis |
F | 52 | High-grade T3 |
M | 70 | High-grade T4 |